Related Experiment Video
Updated: Jun 14, 2025

09:39
Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1
Published on: February 13, 2018
9.5K
Neurotrophins in Peripheral Neuropathy: Exploring Pathophysiological Mechanisms and Emerging Therapeutic
Suman Samaddar1, Moqbel Ali Moqbel Redhwan2, Mohan Muttanahally Eraiah3
1Research Institute, BGS Global Institute of Medical Sciences, Bengaluru, Karnataka, India.
CNS & Neurological Disorders Drug Targets
|September 6, 2024
Summary
Neurotrophins are vital for peripheral nerve health, and their imbalance causes neuropathy. Understanding neurotrophin signaling offers potential therapeutic strategies for nerve disorders.
Area of Science:
- Neuroscience
- Molecular Biology
- Pathology
Background:
- Peripheral neuropathies are diverse nervous system disorders with complex etiologies.
- Neurotrophins, including NGF, BDNF, NT-3, and NT-4, are critical for neuronal survival and function.
- Maintaining neurotrophin balance is essential for peripheral nerve integrity.
Purpose of the Study:
- To review the role of neurotrophins in peripheral neuropathy.
- To explore the pathophysiological consequences of neurotrophin dysregulation.
- To identify neurotrophins as potential therapeutic targets for neuropathic conditions.
Main Methods:
- Literature review of studies on neurotrophins and peripheral neuropathies.
- Analysis of neurotrophin signaling pathways involving Trk and p75(NTR) receptors.
- Examination of neurotrophin involvement in conditions like diabetic and chemotherapy-induced neuropathy.
Main Results:
- Neurotrophin dysregulation is implicated in the pathogenesis of various peripheral neuropathies.
- Altered neurotrophin signaling leads to impaired nerve function and regeneration.
- Neurotrophins show promise in promoting neuronal survival and axonal repair.
Conclusions:
- Understanding neurotrophin signaling is key to developing new treatments for peripheral neuropathies.
- Neurotrophins offer potential for disease-modifying therapies targeting nerve regeneration and functional recovery.
- Challenges remain in clinical translation, including delivery and stability of neurotrophin-based therapies.
Related Concept Videos
Neurogenesis and Regeneration of Nervous Tissue
745
In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...
745
Parkinson's Disease: Overview
499
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
499

